CD44 expression was highly correlated with tumor TNM classification (I+II vs. III+IV)(OR 2.38, 95 % CI 1.23–4.60, P = 0.01, fixed-effect) (Fig. 2a). The gene discussed is CD44; the disease is neoplasm.